Complementary and alternative practices in rheumatology

Best Practice and Research: Clinical Rheumatology

Volumn 22, Issue 4, 2008, Pages 741-757

  Ramos Remus, Cesar ^a   Raut, Ashwinikumar ^b  

^a SJAD ^*  (Mexico)

^b Medical Research Centre of Kasturba Health Society   (India)

Author keywords

alternative therapies; arthritis; CAM therapies; complementary therapies; epidemiology; herbs; rheumatic diseases

Indexed keywords

ANALGESIC AGENT; AYURVEDIC DRUG; BENZODIAZEPINE DERIVATIVE; CHINESE DRUG; COMMIPHORA WIGHTII EXTRACT; CURCUMA LONGA EXTRACT; EPHEDRINE; FISH OIL; GINGER EXTRACT; GINSENG EXTRACT; GLUCOSAMINE SULFATE; HYPERICUM PERFORATUM EXTRACT; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; SEMECARPUS ANACARDIUM EXTRACT; STEROID; TINOSPORA CORDIFOLIA EXTRACT; VITAMIN; WITHANIA SOMNIFERA EXTRACT;

ACUPUNCTURE; ALTERNATIVE MEDICINE; CHINESE MEDICINE; CHIROPRACTIC; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; COMMIPHORA; COMMIPHORA WIGHTII; COST EFFECTIVENESS ANALYSIS; CULTURAL FACTOR; DIET THERAPY; DRUG CONTAMINATION; EVIDENCE BASED MEDICINE; FIBROMYALGIA; HEALTH BEHAVIOR; HEALTH CARE COST; HEALTH CARE UTILIZATION; HUMAN; MARKETING; MASS MEDIUM; MEDICAL LITERATURE; MEDLINE; OSTEOARTHRITIS; PATIENT SAFETY; PATIENT SATISFACTION; PRIORITY JOURNAL; PUBLICATION; REVIEW; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SOCIAL NETWORK;

COMPLEMENTARY THERAPIES; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MUSCULOSKELETAL DISEASES; PATIENT ACCEPTANCE OF HEALTH CARE; RHEUMATIC DISEASES; SOCIOECONOMIC FACTORS;

EID: 51049107478     PISSN: 15216942     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.berh.2008.05.001     Document Type: Review

References (128)

1. Ernst E., and Cassileth B.R. The prevalence of complementary/alternative medicine in cancer. Cancer 83 (1998) 777-782
2. Verhoef M.J., Sutherland L.R., and Brkich L. Use of alternative medicine by patients attending a gastroenterology clinic. Canadian Medical Association Journal 142 (1990) 121-125
3. Moody G.A., Eaden J.A., Bhakta P., et al. The role of complementary medicine in European and Asian patients with inflammatory bowel disease. Public Health 112 (1998) 269-271
4. Wainapel S.F., Thomas A.D., and Kahan B. Use of alternative therapies by rheabilitation outpatients. Archives of Physical Medicine and Rehabilitation 79 (1998) 1003-1005
5. Cohen C.J., Eisenberg D.M., Mayer K.H., and Delblanco T.L. Prevalence of alternative medical treatments in HIV-infected patients: implications for primary care. [abstract]. Clinical Research 38 (1990) 692
6. McGinnis L.S. Alternative therapies, 1990: an overview. Cancer 67 (1991) 1788-1792
7. Smart H.L.A., Mayberry J.F., and Atkinson M. Alternative medicine consultations and remedies in patients with the irritable bowel syndrome. Gut 27 (1986) 826-828
8. Singh P., Yadav R.J., and Pandey A. Utilization of indigenous systems of medicine & homeopathy in India. Indian Journal of Medical Research 122 (2005) 137-142
9. Kronenfeld J.J., and Wasner C. The use of unortodox therapies and marginal practitioners. Social Science & Medicine 16 (1982) 1119-1125
10. Cronan T.A., Kaplan R.M., and Kozin F. Factors affecting unprescribed remedy use among people with self-reported arthritis. Arthritis Care and Research 6 (1993) 149-155
11. Chandrashekara S., Anilkumar T., and Jamuna S. Complementary and alternative therapy in arthritis. The Journal of the Association of Physicians of India 50 (2002) 225-227
12. Zaman T., Agrawal S., and Handa R. Complimentary and alternative medicine use in rheumatoid arthritis: an audit of patients visiting a tertiary care centre. National Medical Journal of India 20 (2007) 236-239
13. Tembe A.G., Kharbanda P., Bhojani K., and Joshi V.R. Profile of rheumatoid arthritis patients: a questionnaire based study from a private hospital. [abstract]. Indian Journal of Rheumatology 2 (2007) S17
14. Pioro-Boisset M., Esdaile J.M., and Fitzcharles M.A. Alternative medicine use in fibromyalgia syndrome. Arthritis Care and Research 9 (1996) 13-17
15. Lind B.K., Lafferty W.E., Tyree P.T., et al. Use of complementary and alternative medicine providers by fibromyalgia patients under insurance coverage. Arthritis and Rheumatism 57 (2007) 71-76
16. Ramos-Remus C., Watters C.A., Dyke L., et al. Assessment of health locus of control in the use of non-conventional remedies by patients with rheumatic diseases. The Journal of Rheumatology 26 (1999) 2468-2474
17. Ramos-Remus C., Gamez-Nava J.I., Gonzalez-Lopez L., et al. Use of non-conventional therapies by patients with rheumatic diseases in Guadalajara, Mexico: prevalence, beliefs and expectations. Arthritis Care and Research 11 (1998) 411-418
18. Singh V., Raidoo D.M., and Harries C.S. The prevalence, patterns of usage and people's attitude towards complementary and alternative medicine (CAM) among the Indian community in Chatsworth, South Africa. BMC Complementary and Alternative Medicine 4 (2004) 3
19. Ramos-Remus C., Gamez-Nava J.I., Gonzalez-Lopez L., and Suarez-Almazor M.E. Use of alternatiave medicine in a consecutive sample of patients with systemic lupus erythematosus. The Journal of Rheumatology 24 (1997) 2490-2491
20. Gordon N.P., Sobel D.S., and Tarazona E.Z. Use of and interest in alternative therapies among adult primary care clinicians and adult members in a large health maintenance organization. Western Journal of Medicine 169 (1998) 153-161
21. Borkan J., Neher J., Anson O., and Smoker B. Referrals for alternative therapies. The Journal of Family Practice 39 (1994) 545-550
22. Varma U., Sharma R., Gupta P., et al. Allopathy v/s Ayurvedic practices in tertiary care institutions of urban north India. Indian Journal of Pharmacology 39 (2007) 52-54
23. Verhoef M.J., and Sutherland L.R. Alternative medicine and general practitioners. Canadian Family Physician 41 (1995) 1005-1011
24. Wharton R., and Lewith G. Complementary medicine and the general practitioner. BMJ (Clinical Research Ed.) 292 (1986) 1498-1500
25. Himmel W., Schulte M., and Kochen M.M. Complementary medicine: are patients' expectations being met by their general practitioners?. The British Journal of General Practice 43 (1993) 232-235
26. Ernst E., and Kaptchuk T.J. Complementary medicine - the case for dialogue. Journal of the Royal College of Physicians of London 30 (1996) 410-412
27. van Haselen R.A., Reiber U., Nickel I., et al. Providing complementary and alternative medicine in primary care: the primary care workers' perspective. Complementary Therapies in Medicine 12 (2004) 6-16
28. Widmer M., Herren S., Dönges A., et al. Complementary and conventional medicine in Switzerland: comparing characteristics of general practitioners. Forschende Komplementärmedizin 13 (2006) 234-240
29. Giannelli M., Cuttini M., Da Frè M., and Buiatti E. General practitioners' knowledge and practice of complementary/alternative medicine and its relationship with life-styles: a population-based survey in Italy. BMC Family Practice 15 8 (2007) 30
30. Cohen M.M., Penman S., Pirotta M., and Da Costa C. The integration of complementary therapies in Australian general practice: results of a national survey. Journal of Alternative and Complementary Medicine (New York, N.Y.) 11 (2005) 995-1004
31. Berman B.M., Bausell R.B., and Lee W.L. Use and referral patterns for 22 complementary and alternative medical therapies by members of the American College of Rheumatology: results of a national survey. Archives of Internal Medicine 162 (2002) 766-770
32. Astin J.A. Why patients use alternative medicine. The Journal of the American Medical Association 279 (1998) 1548-1553
33. Bernstein J.H., and Shuval J.T. Nonconventional medicine in Israel: consultation patterns of the Israeli population and attitudes of primary care physicians. Social Science & Medicine 44 (1997) 1341-1348
34. Eisenberg D.M., Kessler R.C., Foster C., et al. Unconventional medicine in the United States. The New England journal of medicine 328 (1993) 246-252
35. MacLennan A.H., Wilson D.H., and Taylor A.W. Prevalence and cost of alternative medicine in Australia. The Lancet 347 (1996) 569-573
36. Millar W.J. Revue Canadienne de Sante Publique 88 (1997) 154-158
37. Verhoef M.J., Russell M.L., and Love E.J. Alternative medicine use in rural Alberta. Revue Canadienne de Sante Publique 85 (1994) 308-309
38. Boisset M., and Fittzcharles M.A. Alternative medicine use by rheumatic patients in a universal health care setting. The Journal of Rheumatology 21 (1994) 148-152
39. McGinnis J.M., and Foege W.H. Actual causes of death in the United States. The Journal of the American Medical Association 270 (1993) 2207-2212
40. Callahan L.F., and Pincus T. Education, self-care, and outcomes of rheumatic diseases: further challenges to the 'biomedical model' paradigm. Arthritis Care and Research 10 (1997) 283-288
41. Ramos-Remus C., Salcedo-Rocha A.L., Prieto-Parra R., and Galvan-Villegas F. How important is patient education?. Baillière's Best Practice & Research Clinical Rheumatology 14 (2000) 689-703
42. Ries A., and Trout J. Positioning: the battle for your mind (2000), McGraw-Hill
43. Lynch N., and Berry D. Differences in perceived risks and benefits of herbal, over-the-counter conventional, and prescribed conventional, medicines, and the implications of this for the safe and effective use of herbal products. Complementary Therapies in Medicine 15 (2007) 84-91
44. Barnes J., Mills S.Y., Abbot N.C., et al. Different standards for reporting ADRs to herbal remedies and conventional OTC medicines: face-to-face interviews with 515 users of herbal remedies. British Journal of Clinical Pharmacology 45 (1998) 496-500
45. Aceves F.J., Medina F., and Fraga A. Herbal therapies in rheumatology: the persistence of ancient medical practices. Clinical and Experimental Rheumatology 19 (2001) 177-183
46. Lee G.B., Charn T.C., Chew Z.H., and Ng T.P. Complementary and alternative medicine use in patients with chronic diseases in primary care is associated with perceived quality of care and cultural beliefs. Family Practice 21 (2004) 654-660
47. Chao M.T., Wade C., Kronenberg F., et al. Women's reasons for complementary and alternative medicine use: racial/ethnic differences. Journal of Alternative and Complementary Medicine (New York, N.Y.) 12 (2006) 719-720
48. Vandebroek I., Thomas E., Sanca S., et al. Comparison of health conditions treated with traditional and biomedical health care in a Quechua community in rural Bolivia. Journal of Ethnobiology and Ethnomedicine 4 (2008) 1
49. Barlow J.H., Macey S.J., and Struther G.R. Gender, depression and ankylosing spondylitis. Arthritis Care and Research 6 (1993) 45-51
50. Wallston K.A., Wallston B.S., Kaplan G., and Maides S. Development of the multidimensional health locus of control (MHLC) scales. Health Education Monographs 6 (1978) 160-170
51. Gawande A. Annals of medicine: the way we age now. The New Yorker (April 30, 2007) 50-59
52. Suarez-Almazor M.E., Kendall C.J., and Dorgan M. Surfing the net- information on the World Wide Web for persons with arthritis: patient empowerment or patient deceit?. The Journal of Rheumatology 28 (2001) 185-191
53. van Winkelen P., van Dendersen J.S., Vossen C.Y., et al. How evidence-based are advertisements in journals regarding the subspecialty of rheumatology?. Rheumatology (Oxford, England) 45 (2006) 1154-1157
54. Bubela T., Koper M., Boon H., and Caulfield T. Media portrayal of herbal remedies versus pharmaceutical clinical trias: impacts on decision. Medicine and Law 26 (2007) 363-373
55. Weeks L., Verhoef M., and Scott C. Presenting the alternative: cancer and complementary and alternative medicine in the Canadian print media. Support Care Cancer 15 (2007) 931-938
56. Jarvis W.T. Quackery: the National Council against health fraud perspective. Rheumatic Diseases Clinics of North America 25 (1999) 805-814
57. Ramos-Remus C., Gutierrez-Ureña S., and Davis P. Epidemiology of complementary and alternative practices in rheumatology. Rheumatic Diseases Clinics of North America 25 (1999) 789-804
58. Ramos-Remus C., and Aceves Avila F.J. Enfermedades reumáticas: ¿Un mismo problema para el paciente y el reumatólogo. Revista Mexicana De Reumatología 18 (2003) S14
59. Suarez-Almazor M.E., Berrios-Rivera J.P., Cox V., et al. Initiation of disease-modifying antirheumatic drug therapy in minority and disadvantage patients with rheumatoid arthritis. The Journal of Rheumatology 34 (2007) 2400-2407
60. Aceves-Avila F.J., Ferrari R., and Ramos-Remus C. New insights into culture driven disorders. Best Practice & Research Clinical Rheumatology 18 (2004) 155-171
61. Yu W.Y., Shen S.W., and Yang Z.H. A clinical study of Sougudan granule in the treatment of rheumatoid arthritis. Chinese Journal of Integrative Medicine 11 (2005) 255-259
62. Zhang G.G., Lee W., Bausell B., et al. Variability in the traditional Chinese medicine (TCM) diagnoses and herbal prescriptions provided by three TCM practitioners for 40 patients with rheumatoid arthritis. Journal of Alternative and Complementary Medicine (New York, N.Y.) 11 (2005) 415-421
63. Zhang G.G., Lee W.L., Lao L., et al. The variability of TCM pattern diagnosis and herbalprescription on rheumatoid arthritis patients. Alternative Therapies in Health and Medicine 10 (2004) 58-63
64. He Y., Lu A., Zha Y., et al. Correlations between symptoms as assessed in traditional chinece medicine (TCM) and ACR20 efficacy response: a comparison study in 396 patients with rheumatoid arthritis treated with TCM or Western Medicine. Journal of Clinical Rheumatology 13 (2007) 317-321
65. Li E.K., Tam L.S., Wong C.K., et al. Safety and efficacy of Ganoderma lcidum(lingzhi) and San Miao San supplementation in patients with rheumatoid arthritis: a double-blind, randomized, placebo-controlled pilot trial. Arthritis and Rheumatism 57 (2007) 1143-1150
66. Boutron I., Tubach F., Giraudeau B., and Ravaud P. Methodological differences in clinical trials evaluating nonpharmacological and pharmacological treatments of hip and knee osteoarthritis. The Journal of the American Medical Association 290 (2003) 1062-1070
67. Cook C., and Baisden D. Ancillary use of folk medicine by patients in primary care clinics in Southwestern West Virginia. Southern Medical Journal 79 (1986) 1098-1101
68. Fisher P., and Ward A. Complementary medicine in Europe. BMJ (Clinical Research Ed.) 309 (1994) 107-110
69. Larrey D., Vial T., Pauwels A., et al. Hepatitis after germander (Teucrium chamaedrys) administration: another instance of herbal medicine hepatotoxicity. Annals of Internal Medicine 117 (1992) 129-132
70. Lawrence R.C., Helmick Ch G., Arnett F., et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis and Rheumatism 41 (1998) 778-799
71. Katz M., and Saibil F. Herbal hepatitis: subacute hepatic necrosis secondary to chaparral leaf. Journal of Clinical Gastroenterology 12 (1990) 203-206
72. Mohabbat O., Younos M.S., Merzad A.A., et al. An outbreak of hepatic veno-occlusive disease in north-western Afghanistan. Lancet 2 (1976) 269-271
73. Davis C. Risks of manipulation. Journal of the Royal Society of Medicine 87 (1994) 182
74. Borins M. The dangers of using herbs. Postgraduate Medicine 104 (1998) 91-100
75. Ernst E. Harmless herbs? A review of the recent literature. American Journal of Medicine 104 (1998) 170-178
76. Gertner E., Marshall P.S., Filandrinos D., et al. Complications resulting from the use of Chinese herbal medications containing undeclared prescription drugs. Arthritis and Rheumatism 38 (1995) 614-617
77. Goldman J.A. Chinese herbal medicine: camouflaged prescription antiinflammatory drugs, corticosteroids, and lead. Arthritis and Rheumatism 34 (1991) 1207
78. Ries C.A., and Sahud M.A. Agranulocytosis caused by Chinese herbal medicines: dangers of medications containing aminopyrine and phenylbutazone. The Journal of the American Medical Association 231 (1975) 352-355
79. Huang W.F., Wen K.-C., and Hsiao M.-L. Adulteration by synthetic therapeutic substances of traditional Chinese medicines in Taiwan. Journal of Clinical Pharmacology 37 (1997) 344-350
80. Yu H., Zhong S., Chan K., et al. Pharmacognostical investigations on traditional Chinese medicinal herbs. The Journal of Pharmacy and Pharmacology 47 (1995) 1129-1131
81. Cui J., Garle M., Eneroth P., and Björkhem I. What do commercial ginseng preparations contain?. The Lancet 344 (1994) 134
82. Russell A.S., Aghazadeh-Habashi A., and Jamali F. Active ingredient consistency of commercially available glucosamine sulfate products. The Journal of Rheumatology 29 (2002) 2407-2409
83. Draves A.H., and Walker S.E. Analysis of the hypericin and pseudohypericin content of commercially available St John's Wort preparations. The Canadian Journal of Clinical Pharmacology 10 (2003) 114-118
84. Ko R.J. Adulterants in Asian patent medicines. The New England Journal of Medicine 339 (1998) 847
85. Miller G.M., and Tripp R. A study of western pharmaceuticals contained within samples of Chinese herbal/patent medicines collected from New York City's Chinatown. Legal Medicine (Tokyo, Japan) 9 (2007) 258-264
86. Espinoza E.O., and Mann M.-J. Arsenic and Mercury in traditional Chinese herbal balls. The New England Journal of Medicine 33 (1995) 803-804
87. Obt A.B., Oh J.Y., Huntington R.A., and Burkhart K.K. Chinese herbal medicine induces acute renal failure. Archives of Internal Medicine 155 (1995) 211-212
88. But P.P. Herbal poisoning caused by adulterants or erroneous substitutes. The Journal of Tropical Medicine and Hygiene 97 (1994) 371-374
89. Slifman N., Obermeyer W.R., Aloi B.K., et al. Contamination of botanical dietary supplements by digitalis lanata. The New England Journal of Medicine 339 (1998) 806-811
90. Cooper K., Noller B., Connell D., et al. Public health risks from heavy metals and metalloids present in traditional Chinese medicines. Journal of Toxicology and Environmental Health. Part A 70 (2007) 1694-1699
91. Shaw D., Leon C., Kolev S., and Murray V. Traditional remedies and food supplements. A 5-year toxicological study (1991-1995). Drug Safety 17 (1997) 342-356
92. DiPaola R.S., Zhang H., Lambert G.H., et al. Clinical and biologic activity of an estrogenic herbal combination (PC-SPES) in prostate cancer. The New England Journal of Medicine 339 (1998) 785-791
93. Pietroni P.C. Beyond the boundries: relationship between general practice and complementary medicine. BMJ (Clinical Research Ed.) 305 (1992) 564-566
94. Thomas K.J., Carr J., Westlake L., and Williams B.T. Use of non-orthodox and conventional healthcare in Britain. British Medical Journal 302 (1991) 207-210
95. Oldendick R., Coker A.L., Wieland D., et al. Population-based survey of complementary and alternative medicine usage, patient satisfaction, and physician involvement. South Carolina Complementary Medicine Program Baseline Research Team. Southern Medical Journal 93 (2000) 375-381
96. Panush R.S. Reflections on unproven remedies. Rheumatic Diseases Clinics of North America 19 (1993) 201-206
97. Busato A., Dönges A., Herren S., et al. Health status and health care utilisation of patients in complementary and conventional primary care in Switzerland-an observational study. Family Practice 23 (2006) 116-124
98. Coopes M.J., Anderson R.A., Egeler R.M., and Wolff J.E. Alternative therapies for the treatment of childhood cancer. The New England Journal of Medicine 339 (1998) 846
99. Barnes J. Pharmacovigilance of herbal medicines: a UK perspective. Drug Safety 26 (2003) 829-851
100. British Medical Association. Complementary medicine: new approaches to good practice (1993), Oxford University Press, Oxford
101. Patwardhan B., Warude D., Pushpangadan P., and Bhatt N. Ayurveda and traditional Chinese medicine: a comparative overview. Evidence-based Complementary and Alternative Medicine 2 (2005) 465-473
102. Available from. http://indianmedicine.nic.in/html/ayurveda/afmain.htm
103. Vaidya AB. Effective Integration of Indian Systems of Medicine in Health Care delivery: People's participation, Access and Choice in a Pluralistic Democracy, Financing and Delivery of healthcare services in India, National Commission on Macroeconomics and Health, Ministry of Health & Family Welfare, Government of India, New Delhi, August 2005. p. 77-87.
104. Vaidya A.D.B. Reverse pharmacological correlates of ayurvedic drug actions. Indian Journal of Pharmacology 38 (2006) 311-315
105. Ashwinikumar A. Raut, Ashok D.B.Vaidya. Reverse pharmacology: application to ayurvedic medicine. In: Proceedings of second national seminar on evidence based and integrated medicine for lymphatic filariasis, other chronic dermatoses and HIV/AIDS, Kasargod, Kerala, S. India; February 2007. p. 47-52.
106. Raut A.A., Sarkar S., Sudha S., et al. Commiphora wightii (Guggulu) induced downregulation of macrophage released cytokines in vitro. Indian Drugs 44 (2007) 39-42
107. Singh B.B., Mishra L.C., Vinjamury S.P., et al. The effectiveness of Commiphora mukul for osteoarthritis of the knee - an outcome study. Alternative Therapies in Health and Medicine 3 (2003) 74-79
108. Deodhar S.D., Sthi R., and Srimal R.C. Preliminary study on antirheumatic activity of Curcumin (diferulolyl methane). Indian Journal of Medical Research 71 (1980) 632-634
109. Kulkarni R.R., Patki P.S., Jog V.P., et al. Treatment of osteoarthritis with a herbomineral formulation: a double blind, placebo-controlled, cross-over study. Journal of Ethnopharmacology 33 (1991) 91-95
110. White B. Ginger an overview. American Family Physician 75 (2007) 1689
111. Altman R.D., and Marcussen K.C. Effects of a ginger extract on knee pain in patients with osteoarthritis. Arthritis and Rheumatism 44 (2001) 2531
112. Chopra A., Raut A., Bichile L., et al. A Controlled Drug Trial to Evaluate Ayurvedic Derived Shunthi-Guduchi Based Standard Formulations in the Treatment of Osteoarthritis (OA) Knees: a Government of India NMITLI Arthritis Project. [abstract]. Annals of the Rheumatic Diseases 65 Suppl. 11 (2006) 226-227
113. Chopra A., Narsimulu G., Bichile L., et al. Comparing ayurvedic (India) herbal drugs and HCQS (hydroxychloroquin sulphate) in the treatment of rheumatoid arthritis (RA): randomized, double blind, multi-centric exploratory drug trial of 24 weeks duration. [abstract]. Arthritis and Rheumatism 56 Suppl. 9 (2007) S394-S395
114. Raut A.A., Sawant N.S., Badre A.S., et al. A controlled drug trial to evaluate ayurvedic derived Shunthi-Guduchi based standard formulations in the treatment of kar, A.D.B. Vaidya. Bhallatak (Semecarpus anacardium Linn) - a review. Indian Journal of Traditional Knowledge 6 (2007) 653
115. Bajpai H.S., Sathyavati G.V., Agrawal U., et al. Role of Semecarpus anacardium Linn (Bhallatak) in the treatment of arthropathies - a preliminary report. The Journal of Research in Indian Medicine 5 (1970) 1
116. Raut AA, Bichile LS, Chopra AR, et al, (abst) in Souvenir of 'Amritbhallatak in Osteoarthritis: Exploratory Clinical Study' in second World Ayurveda Congress held at Pune on 11th November 2006.
117. Chopra A., Lavin P., Patwardhan B., and Chitre D. A 32 week randomized, placebo - controlled clinical evaluation of RA-11, an ayurvedic drug, on osteoarthritis of the knees. Journal of Clinical Rheumatology 10 (2004) 236-245
118. Spigelblatt L., Lainé-Ammara G., Pless I.B., and Guyver A. The use of alternative medicine by children. Pediatrics 94 (1994) 811-814
119. Feinglass J., Lee C., Rogers M., et al. Complementary and alternative medicine use for arthritis pain in 2 Chicago community areas. The Clinical Journal of Pain 23 (2007) 744-749
120. Use of complementary and alternative medicine by persons with arthritis: results of the National Health Interview Survey. Arthritis and Rheumatism 53 (2005) 748-755
121. Rao J.K., Kroenke K., Mihaliak K.A., et al. Rheumatology patients' use of complementary therapies: results from a one-year longitudinal study. Arthritis and Rheumatism 49 (2003) 619-625
122. Kaboli P.J., Doebbeling B.N., Saag K.G., and Rosenthal G.E. Use of complementary and alternative medicine by older patients with arthritis: a population-based study. Arthritis and Rheumatism 45 (2001) 398-403
123. Rao J.K., Mihaliak K., Kroenke K., et al. Use of complementary therapies for arthritis among patients of rheumatologists. Annals of Internal Medicine 131 (1999) 409-416
124. Alvarez-Nemegyei J., and Bautista-Botello A. Association of complementary or alternative therapy use with quality of life, functional status or cumulated damage in chronic rheumatic diseases. Clinical Rheumatology 2 (2007) 45
125. Kestin M., Miller L., Littlejohn G., and Wahlqvist M. The use of unproven remedies for rheumatoid arthritis in Australia. Medical Journal of Australia 143 (1985) 516-518
126. Vecchio P.C. Attitudes to alternative medicine by rheumatology outpatient attenders. The Journal of Rheumatology 21 (1994) 145-147
127. Buchbinder R., Gingold M., Hall S., and Cohen M. Non-prescription complementary treatments used by rheumatoid arthritis patients attending a community-based rheumatology practice. Internal Medicine Journal 32 (2002) 208-214
128. Rainer F., Ulreich A., and Pfeiffer K.P. Art und ausmaß der selbstmedikation mit sogenannten hausmitteln' bei patienten mit rheumatischen erkrankungen. Zeitschrift für Rheumatologie 41 (1982) 276-279